姓名 | 職稱 | 持有股份 | 代表法人 |
---|---|---|---|
Chen,Wen-Zong | Chairman | 4.25% | |
Tang,Jin-Xian | Director | 5.00% | |
Cai,He-Xin | Director | 2.37% | |
Zhou,Yin-Zhong | Independent Director | 0.00% | |
Lin,Quan | Independent Director | 0.00% | |
Zhou,Yu-Zheng | Independent Director | 0.00% | |
Cao,Xian-Jin | Independent Director | 0.00% |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Operating income | 78,769 | 280,934 | 251,831 |
Operating cost | 43,799 | 159,517 | 143,884 |
Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
Operating gross profit (loss) | 34,970 | 121,417 | 107,947 |
Unrealized profit (loss) on sales of goods | - | - | - |
Realized profit (loss) on sales of goods | - | - | - |
Operating gross profit (loss), net | 34,970 | 121,417 | 107,947 |
Operating expenses | 17,115 | 60,897 | 59,619 |
Other gain (loss), net | - | - | - |
Operating profit (loss) | 17,855 | 60,520 | 48,328 |
Non-operating income and expenses | 1,547 | 8,729 | 4,445 |
Net profit (loss) before tax | 19,402 | 69,249 | 52,773 |
Income tax expense (benefits) | 3,880 | 13,853 | 10,555 |
Net profit (loss) of ongoing business for the current period | 15,522 | 55,396 | 42,218 |
Profit (loss) of closed units | - | - | - |
Profit (loss) of non-jointly controlled equity before merger | - | - | - |
Net profit (loss) for the current period | 15,522 | 55,396 | 42,218 |
Other comprehensive profit (loss), net | - | -2 | 35 |
Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
Total comprehensive profit and loss for the current period | 15,522 | 55,394 | 42,253 |
Net profit (loss) attributable to owners of parent company | - | - | - |
Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Net profit (loss) attributable to non-controlling interests | - | - | - |
Comprehensive profit (loss) attributable to owners of parent company | - | - | - |
Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
Basic earnings per share (yuan) | 0 | 1 | 1 |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Net cash inflow (outflow) from operating activities | - | - | - |
Net cash inflows (outflows) from investing activities | - | - | - |
Net cash inflow (outflow) from financing activities | - | - | - |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
Increase (decrease) in cash and cash equivalents in the current period | - | - | - |
Beginning balance of cash and cash equivalents | - | - | - |
Ending balance of cash and cash equivalents | - | - | - |
項目 | 2025 | 2024 | 2023 |
---|---|---|---|
Current asset | 534,608 | 519,022 | 491,632 |
Non-current asset | 20,060 | 22,496 | 23,560 |
Total asset | 554,668 | 541,518 | 515,192 |
Current liability | 65,821 | 67,064 | 56,664 |
Non-current liability | 782 | 1,911 | 879 |
Total liability | 66,603 | 68,975 | 57,543 |
share capital | 337,500 | 337,500 | 337,500 |
Equity - secruity token | - | - | - |
capital reserve | 49,286 | 49,286 | 51,817 |
retained earning | 101,279 | 85,757 | 68,332 |
Other equity | - | - | - |
Treasury stock | - | - | - |
Total equity attributable to owners of parent company | - | - | - |
Equity attributable to former owner of business combination under common control | - | - | - |
Equity attributable to non-controlling interest before business merger under common control | - | - | - |
Non-controlling interests | - | - | - |
Total Equity | 488,065 | 472,543 | 457,649 |
Share capital awaiting retirement (unit: share) | - | - | - |
Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
Net asset value per share | 14 | 14 | 13 |